Business Wire

MA-DESKTOP-METAL

19.4.2022 14:32:12 CEST | Business Wire | Press release

Share
Desktop Metal Introduces the All-New S-Max® Flex, a Robotic Additive Manufacturing 2.0 System that Makes Sand 3D Printing Affordable to Foundries Worldwide

Desktop Metal (NYSE: DM) today announced the launch of the ExOne S-Max® Flex, a scalable, large-format binder jetting system that 3D prints sand tooling, which foundries use to quickly cast complex metal designs for the aerospace, automotive, and energy industries, among others.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220419005064/en/

ExOne, which was acquired by Desktop Metal in late 2021, is the leading digital sand printing solution provider for foundries. The new S-Max Flex combines ExOne’s sand printing expertise in process and materials with proprietary Desktop Metal SPJ technology in an affordable architecture to deliver new value to foundries that have long wanted an S-Max but found the premium price out of reach.

The S-Max Flex will debut at CastExpo 2022, North America’s largest metalcasting trade show, from April 23-26 in Columbus, Ohio. A video highlighting the benefits of the S-Max Flex for early customers, including Alpha Foundry of Wright City, Mo., and D.W. Clark in Taunton, Mass., was released today at www.exone.com/flexvideo .

“To achieve our vision of Additive Manufacturing 2.0, we need to make production 3D printing practical in terms of speed, cost, and material availability for a broad range of applications,” said Ric Fulop, Co-Founder and CEO of Desktop Metal. “We designed the all-new S-Max Flex from the ground up leveraging SPJ technology with the idea of making premium sand 3D printing accessible to every foundry, so that more companies can take advantage of the benefits of AM 2.0, such as distributed, local production, and remain competitive for the long term.”

The S-Max Flex comes to market at a time of strong demand for castings, along with challenges finding labor. After years of contraction, the U.S. metalcasting industry is experiencing growth as a result of supply chain changes related to the COVID-19 pandemic. A recent survey released by the American Foundry Society shows that 90 percent of responding North American foundries have a positive business outlook and anticipate making capital investments in the next 12 months, including of 3D printers.

Additional early buyers of the new S-Max Flex include Founders Service & Manufacturing Co. Inc. of Deerfield, Ohio, and HTCI Co. of New Carlisle, Ohio.

Details of the S-Max Flex
The S-Max Flex pairs an affordable industrial robot with an all-new end effector printhead design that deposits binder into a 1900 x 1000 x 1000 mm (74 x 39 x 39 in) telescoping build box that grows as the parts are built layer by layer. Additional build box sizes are available up to 4700 x 1000 x 1000 mm (185 x 39 x 39 in), with taller versions available up to 1000 x 2500 x 2400 mm (39 x 98 x 94 in).

Desktop Metal’s high throughput SPJ technology delivers a build rate up to 115 l/h, which offers foundries quick and reliable production to operate more efficiently in times of ongoing labor shortages, as well as a faster return on investment. The S-Max Flex joins the premium S-Max® and S-Max® Pro solutions that are used in foundries worldwide.

The all-new S-Max Flex prints standard silica sand with furan binders and delivers final parts with dimensional accuracy of +/- 0.5 mm. The system comes with several accessories and safety features that are configurable to fit a variety of spaces.

Industries beyond metalcasting are also set to take advantage of the S-Max Flex’s large form factor and ability to binder jet a variety of powders. Infiltrated sand tooling for plastic thermoforming, composite layup, and sacrificial tooling applications are printed today on S-Max machines, along with infiltrated sand consumer products, such as those offered by Sandhelden and Deeptime . Desktop Metal’s Forust brand, which upcycles byproducts of the wood waste stream into consumer designs, will also leverage the new system to print large form factor wood parts at scale cost-effectively. Additional projects are underway printing reclaimed concrete and other materials.

Binder Jetting - the Fastest AM Method for Mass Production
Binder jet 3D printing is widely regarded as the fastest additive manufacturing method for the mass production of functional precision parts. Sand binder jet 3D printing has been used in foundries for more than two decades to create metalcasting tooling cost-effectively and with low turnaround times.

In the binder jetting process, an industrial printhead selectively deposits a binder into a bed of sand particles creating a solid part one thin layer at a time, similar to printing on sheets of paper. 3D printing straight from CAD files enables foundries to eliminate the months-long lead times and high costs of traditional patterns and coreboxes created from wood or metal. The design freedom of additive manufacturing also allows designers to innovate the parts made with the reliable casting process – creating complex, consolidated geometries that enable lightweighting and optimized part performance not possible with traditional processes.

For more information on the ExOne S-Max Flex system, visit www.exone.com .

About Desktop Metal
Desktop Metal, Inc., based in Burlington, Massachusetts, is accelerating the transformation of manufacturing with an expansive portfolio of 3D printing solutions, from rapid prototyping to mass production. Founded in 2015 by leaders in advanced manufacturing, metallurgy, and robotics, the company is addressing the unmet challenges of speed, cost, and quality to make additive manufacturing an essential tool for engineers and manufacturers around the world. Desktop Metal was selected as one of the world’s 30 most promising Technology Pioneers by the World Economic Forum, named to MIT Technology Review’s list of 50 Smartest Companies, and the 2021 winner of Fast Company’s Innovation by Design Award in materials and Fast Company’s Next Big Things in Tech Award for sustainability. For more information, visit www.desktopmetal.com .

Forward-looking Statements
This press release contains certain forward-looking statements within the meaning of the federal securities laws. Forward-looking statements generally are identified by the words “believe,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “plan,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks, uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this document, including but not limited to, the risks and uncertainties set forth in Desktop Metal, Inc.'s filings with the U.S. Securities and Exchange Commission. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and Desktop Metal, Inc. assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise.

Link:

ClickThru

Social Media:

https://www.facebook.com/DesktopMetal/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press release

- Vertex is on track for the U.S. FDA Prescription Drug User Fee Act (PDUFA) date of November 30 for potential accelerated approval of povetacicept –- Data published in NEJM and presented at ASN highlight povetacicept’s unique trifecta of efficacy, favorable safety, and the simplicity of dosing at-home every 4 weeks with a low-volume autoinjector –- Data presented at ASN include a qualitative study examining patient perspectives on current and emerging IgAN therapies, showing that 96% of participants preferred an autoinjector over a prefilled syringe, and 80% of participants preferred dosing every 4 weeks versus weekly dosing - - New clinical studies of povetacicept underway including a study evaluating patient experience on povetacicept administered via autoinjector - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Soc

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release

New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press release

Collaboration will establish the roadmap for bringing Pony.ai robotaxis to Kazakhstan on the inDrive ride-hailing platform, leveraging the NVIDIA Hyperion and the NVIDIA Halos safety system. inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a lea

Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 14:50:00 CEST | Press release

Phase Ia BreAK CRC-001 at ESMO 2026: 43% of patients, all initially unresectable, became eligible for surgery Poster 1023P – Developmental Therapeutics Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by u

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye